A Review of Hematological Malignancy in Pregnancy



Abstract Views
341

Downloads
236

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted Jun 1, 2021
Published Jun 23, 2021
10.24018/ejmed.2021.3.3.904

Abstract viewed = 341 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

Hematological malignancy in pregnancy is a rare condition which leads to lack of prospective study and randomized control trial. Nevertheless, it has own challenge to the medical field in term of managing patient with the said condition. The dilemma is to decide among the necessities of continuation of pregnancy, the choice of diagnostic tools and chemotherapeutic drugs, and the timing of initiation treatment without disregarding the women's wish and preferences. The process often has a profound psychological burden on patients and family members. Furthermore, delays in diagnosis and intervention will adversely affect the outcomes of pregnancy and the disease itself. The effect of teratogenicity of chemotherapeutic drugs on the fetus and the progression of the disease during pregnancy are the main concern in treating this group of patients. This article will review the management and outcomes of 6 cases of hematological malignancy in pregnancy in one center (3 Hodgkin lymphoma, 1 chronic myeloid leukemia, 1 hairy cell leukemia, and 1 myeloproliferative neoplasms).  The outcomes of the pregnancy cases in this article were five successful live births with one case of early neonatal death due to prematurity with a history of second-trimester loss. The treatment was initiated during the second trimester to reduce the risk of chemotherapy to the fetus. Even though a few cases had fetal growth compromise but the fetal outcomes seem to be good with early interventions and multidisciplinary approached.

Keywords: Leukemia, lymphoma, myeloproliferative neoplasm, pregnancy

Downloads

Download data is not yet available.

References

  1. Lavi N, Horowitz NA, Brenner B. An Update on the Management of Hematologic Malignancies in Pregnancy. Women’s Health. May 2014:255-266.
     Google Scholar
  2. Mahmoud, Hossam K., Mohamed A. Samra, and Gamal M. Fathy. “Hematologic Malignancies during Pregnancy: A Review.” Journal of Advanced Research 1 July 2016: 589–596. Journal of Advanced Research. Web.
     Google Scholar
  3. Sanchez M, Pellicer B, del Puig Cozar M, Martínez-Sanjuan V, Villegas C, Carbonell F. Hodgkin lymphoma in pregnancy: a case report. Clin Adv Hematol Oncol. 2013;11(8):533-536.
     Google Scholar
  4. Connors JM. State-of-the-art therapeutics: Hodgkin’s lymphoma. J Clin Oncol 2005;23:640-840.
     Google Scholar
  5. Lishner M, Zemlickis D, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Maternal and fetal outcome following Hodgkin’s disease in pregnancy. Br J Cancer 1992;65(1):114–7.
     Google Scholar
  6. Weisz B, Meirow D, Schiff E, Lishner M. Impact and treatment of cancer during pregnancy. Expert Rev Anticancer Ther 2004;4 (5):889–902.
     Google Scholar
  7. Pentheroudakis G, Pavlidis N. Cancer, and pregnancy: poena magna, not anymore. Eur J Cancer 2006;42(2):126–40.
     Google Scholar
  8. Palani, R., Milojkovic, D. & Apperley, J.F. Managing pregnancy in chronic myeloid leukemia. Ann Hematol 94, 167–176 (2015).
     Google Scholar
  9. Pons JC, Lebon P, Frydman R, Delfraissy JF. Pharmacokinetics of interferon-alpha in pregnant women and fetoplacental passage. Fetal Diagn Ther 1995;10(1):7–10.
     Google Scholar
  10. Baer MR, Ozer H, Foon KA. Interferon-alpha therapy during pregnancy in chronic myelogenous leukemia and hairy cell leukemia. Br J Hematol 1992; 81:167-169.
     Google Scholar
  11. Mubarak AA, Kakil IR, Awidi A, Al-Homsi U, Fawzi Z, Kelta M, Al-Hassan A (2002) Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon-a in 1st trimester: report of 3 cases and review of the literature. Am J Hematol 69:115–118.
     Google Scholar
  12. Shapira T Preg D & Lishner M How I treat acute and chronic leukemia in pregnancy. Blood Rev 2008;247-259.
     Google Scholar
  13. Hernández-Ruano K, Morales-Santos D, Portillo-Cálix P, et al. Hairy Cell Leukemia - Case Reports. Med Case Rep. 2016, 2:2.
     Google Scholar
  14. J. Kell Williams, Hairy cell leukemia in pregnancy: A case report, American Journal of Obstetrics and Gynecology, Volume 156, Issue 1, 1987, Pages 210-211.
     Google Scholar
  15. Shackleton L, Langabeer SE, O'Brien D, et al. Hairy Cell Leukemia Masquerading as Pancytopenia in Pregnancy. Case Rep Hematol. 2019; 2019:3238168. Published 2019 Aug 21.
     Google Scholar
  16. Treatment of hairy cell leukemia during pregnancy: are purine analogs and rituximab viable therapeutic options. Daver N, Nazha A, Kantarjian HM, Haltom R, Ravandi F Clin Lymphoma Myeloma Leuk. 2013 Feb; 13(1):86-9.
     Google Scholar
  17. Laparoscopic splenectomy for hairy cell leukemia in pregnancy. Adeniji BA, Fallas M, Incerpi M, Hamburg S, Katz R, Ogunyemi D Case Rep Med. 2010.
     Google Scholar
  18. Barbui T, Finazzi G. Special issues in myeloproliferative neoplasms. Curr Hematol Malig Rep 2011;6(1):28–35.
     Google Scholar
  19. Harrison CN, Robinson SE. Myeloproliferative disorders in pregnancy. Hematol Oncol Clin North Am 2011;25(2):261–75.
     Google Scholar
  20. Barbui T, Finazzi G. Myeloproliferative disease in pregnancy and other management issues. Hematology 2006;2006(1):246–52.
     Google Scholar
  21. McMullin MF, Bareford D, Campbell P, Green AR, Harrison C, Hunt B, et al. Guidelines for the diagnosis, investigation, and management of polycythemia/erythrocytosis. Br J Haematol 2005;130(2):174–95.
     Google Scholar
  22. Séror J, Sentilhes L, Lefebvre-Lacoeuille C, Marpeau L. Interferon-alpha for treatment of essential thrombocythemia during pregnancy: case report and review of the literature. Fetal Diagn Ther. 2009;25(1):136-140.
     Google Scholar
  23. Hiratsuka M, Minakami H, Koshizuka S, Sato I. Administration of interferon-alpha during pregnancy: effects on fetus. J Perinat Med. 2000;28(5):372-376.
     Google Scholar
  24. Vantroyen B, Vanstraelen D (2002) Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha 2a and no treatment. A comprehensive analysis of the literature. Acta Hematol 107:158–169.
     Google Scholar
  25. Mathieu P, Emilie C, Fabrice P, Olivier P. Pregnancy and myeloproliferative neoplasms: A retrospective monocentric cohort. Obstet Med. 2017 Dec; 10(4): 165–169.
     Google Scholar